Literature DB >> 23650835

[Inflammatory pseudotumor of the liver: a case of recurrence after resection].

Juan Salceda1, Claude Tayar, Alexis Laurent, Luciani Alain, Daniel Cherqui, Daniel Azoulay.   

Abstract

Inflammatory pseudo-tumor of the liver is a rare benign condition. Usually presented as a large liver mass, may cause obstruction or infiltration of the main vessels or biliary tree. The clinical presentation is mostly an inflammatory syndrome with acute abdominal pain. We present a 39-year-old female patient with abdominal pain, fever and jaundice. Images showed a 15-cm liver lesion in the left lobe of the liver. Malignancy could not be discarded and the patient underwent left hepatectomy. The histologic examination reported an inflammatory pseudo-tumor of the liver. The patient recurred after one year with the same symptoms and a 10-cm new lesion occupying segment I. Considered as a recurrence, medical treatment was decided tumor size decreased 50% after the first month and completely disappeared during the follow up. Two years later, the patient was readmitted with a new episode and a new 8-cm liver lesion in segment VII. She was treated again with anti-inflammatory medication and imaging control. Although inflammatory pseudo-tumor of the liver is a benign condition, it can have a recurrent behaviour. The differentiation with other malignant tumors sometimes is impossible by clinical and imaging presentation.

Entities:  

Mesh:

Year:  2013        PMID: 23650835

Source DB:  PubMed          Journal:  Acta Gastroenterol Latinoam        ISSN: 0300-9033


  2 in total

1.  Fever of unknown origin as a presentation of colonic inflammatory myofibroblastic tumor in a 36-year-old female: A case report.

Authors:  Ru Zhou; Jianbin Xiang; Zongyou Chen; Zhenyang Li; Jun Hong
Journal:  Oncol Lett       Date:  2014-03-05       Impact factor: 2.967

2.  Inflammatory pseudotumor of the liver diagnosed as metastatic liver tumor in a patient with a gastrointestinal stromal tumor of the rectum: report of a case.

Authors:  Yoichi Matsuo; Mikinori Sato; Takahiro Shibata; Mamoru Morimoto; Ken Tsuboi; Tomoya Shamoto; Takahisa Hirokawa; Takafumi Sato; Hiroki Takahashi; Hiromitsu Takeyama
Journal:  World J Surg Oncol       Date:  2014-05-06       Impact factor: 2.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.